MedTrace Logo

A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children

NCT00626808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 321697

Last updated 2014-08-12

Study results available
· View outcomes & findings →

Summary

This is a retrospective cohort study of children included in a large medical insurance claims database.

Conditions

  • Asthma
  • Wheezing
  • Immunosuppression

Interventions

DRUG

No Intervention

There were no interventions. No subjects were enrolled in this retrospective database study.

Sponsors & Collaborators

  • RTI International

    collaborator OTHER

  • MedImmune LLC

    lead INDUSTRY

Principal Investigators

  • Chris Ambrose, M.D. · MedImmune LLC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00626808 on ClinicalTrials.gov